AB0227 TREATMENT SEQUENCING PATTERNS AND COMPARATIVE EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM A REAL-WORLD SETTING
Ai L, Higashi M, Lee K, Liu Z, Jin L, Raja K, Mai Y, Jun T, Oh W, Beckmann A, Schadt E, Schadt Z, Wallsten R, Calay E, Kasarskis A, Pan Q, Schadt E, Wang X. AB0227 TREATMENT SEQUENCING PATTERNS AND COMPARATIVE EFFICACY IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM A REAL-WORLD SETTING. Annals Of The Rheumatic Diseases 2022, 81: 1241. DOI: 10.1136/annrheumdis-2022-eular.4655.Peer-Reviewed Original ResearchDisease-modifying antirheumatic drugsTime to next treatmentConventional synthetic DMARDsDurability of responseRheumatoid arthritisElectronic health recordsAntirheumatic drugsImproved duration of responseConventional synthetic disease-modifying antirheumatic drugsBiologic disease-modifying antirheumatic drugsSynthetic disease-modifying antirheumatic drugsPredictors of disease progressionSecond-line settingSecond-line therapyDuration of responseLines of therapyEuropean League Against RheumatismTime-to-event analysisMethods Electronic health recordsManagement of rheumatoid arthritisCsDMARD combinationSecond-lineAnti-TNFTNFi therapyImprove patient outcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply